82 related articles for article (PubMed ID: 24375558)
1. CD75: a B-cell marker which should not be forgotten in lymphocyte predominant Hodgkin lymphoma.
Carbone A; Gloghini A
Am J Hematol; 2014 Apr; 89(4):449. PubMed ID: 24375558
[No Abstract] [Full Text] [Related]
2. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
3. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
Hanson CA; Morice WG
Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
[No Abstract] [Full Text] [Related]
4. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
Browne P; Petrosyan K; Hernandez A; Chan JA
Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
[TBL] [Abstract][Full Text] [Related]
5. [Pitfalls and update in haematopathology. Case 7. Nodular lymphocyte predominant Hodgkin lymphoma].
Moreau A
Ann Pathol; 2012 Oct; 32(5):363-70. PubMed ID: 23141946
[No Abstract] [Full Text] [Related]
6. Prognostic significance of PU.1 in follicular lymphoma.
Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry.
Carulli G; Marini A
Clin Ter; 2012; 163(1):47-57. PubMed ID: 22362234
[TBL] [Abstract][Full Text] [Related]
8. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
[TBL] [Abstract][Full Text] [Related]
9. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
[TBL] [Abstract][Full Text] [Related]
10. [Pitfalls and update in haematopathology. Case 4: limits of needle biopsies for assessment of lymphoid lesions].
Molina T
Ann Pathol; 2012 Oct; 32(5):346-50. PubMed ID: 23141943
[No Abstract] [Full Text] [Related]
11. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
Huang Q; Wilczynski SP; Chang KL; Weiss LM
Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
[TBL] [Abstract][Full Text] [Related]
12. Microvillous lymphomas are B-cell neoplasms that frequently express CD56.
Hammer RD; Vnencak-Jones CL; Manning SS; Glick AD; Kinney MC
Mod Pathol; 1998 Mar; 11(3):239-46. PubMed ID: 9521469
[TBL] [Abstract][Full Text] [Related]
13. Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings.
Woolf KM; Wei MC; Link MP; Arber DA; Warnke RA
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):196-201. PubMed ID: 18227720
[TBL] [Abstract][Full Text] [Related]
14. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
[TBL] [Abstract][Full Text] [Related]
15. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
16. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
17. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
18. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
[TBL] [Abstract][Full Text] [Related]
19. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
